Drug archive
Docetaxel (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antineoplastic
Description
Docetaxel (doe-se-TAX-el) belongs to the group of medicines called antineoplastics. It is used to treat breast cancer and non-small cell lung cancer.
Docetaxel interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by docetaxel, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects may not be serious but may cause concern. Some effects may not occur for months or years after the medicine is used.
Docetaxel may also be used to treat other conditions as determined by your doctor.
Before you begin treatment with docetaxel, you and your doctor should talk about the good this medicine will do as well as the risks of using it.
Docetaxel is to be administered only by or under the immediate supervision of your doctor. It is available in the following dosage form:
- Injection (U.S. and Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Taxotere
In Canada -
- Taxotere